Form 4: Carmell Corp Director Kathryn Gregory Reports Stock Purchase

Director Kathryn Gregory reports purchasing 1,260 shares of Carmell Corp common stock at $0.51 per share through Carmell Insiders LLC.

Summary

• Kathryn Gregory, a director of Carmell Corp, filed a Form 4 disclosing a purchase of the company's common stock.
• The transaction occurred on September 6, 2024.
• Gregory acquired 1,260 shares at a price of $0.51 per share.
• The purchase was made indirectly through Carmell Insiders LLC.
• Following the transaction, Gregory beneficially owns 22,500 shares indirectly through Carmell Insiders LLC and 62,257 shares directly through stock options.
• Carmell Insiders LLC was formed to allow board members to acquire shares during periods when they are not in possession of material nonpublic information.
• The total amount invested in the LLC by its members was $130,750 as of the date of this filing.
• Gregory's interest in the LLC is 26.4%.

Sentiment

Score: 6

Explanation: The sentiment is neutral to slightly positive. A director purchasing shares is generally a good sign, but the amount is relatively small and the purchase is through an LLC, which somewhat dilutes the signal.

Positives

• A director purchasing shares can be seen as a positive signal, indicating confidence in the company's future prospects.

Industry Context

Insider transactions are closely watched by investors as they can provide insights into management's view of the company's prospects. Purchases are generally viewed more favorably than sales.

Comparison to Industry Standards

• Insider trading activity is a common metric used to assess management confidence across various industries.
• Comparing Gregory's purchase to similar transactions by directors in comparable biotech companies could provide further context.
• For example, if directors at companies like CRISPR Therapeutics or Beam Therapeutics are also making open market purchases, it could signal a broader positive sentiment in the sector.

Stakeholder Impact

• The stock purchase could have a slightly positive impact on shareholder sentiment.

Key Dates

Keywords

Form 4, Carmell Corp, Kathryn Gregory, insider trading, stock purchase, CTCX, beneficial ownership, Carmell Insiders LLC